We are live on ! Find out more
BMEZ icon

BlackRock Health Sciences Trust II

88 hedge funds and large institutions have $215M invested in BlackRock Health Sciences Trust II in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

2% more funds holding

Funds holding: 8688 (+2)

1.25% more ownership

Funds ownership: 12.83%14.08% (+1.3%)

4% more capital invested

Capital invested by funds: $206M → $215M (+$8.99M)

Holders
88
Holders Change
+2
Holders Change %
+2.33%
% of All Funds
1.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
38
Reduced
18
Closed
13
Calls
Puts
Net Calls
Net Calls Change

BMEZ Hedge Fund Activity: Q1 2026 in Review

88 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust II (BMEZ) for Q1 2026, worth a combined $215M — up 4.4% from $206M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BMEZ positions and 13 closed out — a net gain of 3 holders — while 38 added to existing stakes and 18 trimmed.

The largest buyer was Saba Capital Management, opening a new position worth an estimated $11.3M. The largest seller was Penserra Capital Management, cutting an estimated $14.4M.

  • 88 institutional investors held BlackRock Health Sciences Trust II (BMEZ) as of Q1 2026, up from 86 in Q4 2025.
  • Funds reported $215M of BlackRock Health Sciences Trust II stock for Q1 2026, up 4.4% quarter-over-quarter.
  • 16 funds opened new BlackRock Health Sciences Trust II positions in Q1 2026 and 13 closed out, a net change of +3 holders.
  • The largest BlackRock Health Sciences Trust II buyer in Q1 2026 was Saba Capital Management, an estimated $11.3M added.
  • The largest BlackRock Health Sciences Trust II seller in Q1 2026 was Penserra Capital Management, an estimated $14.4M sold.

Based on aggregated 13F filings for Q1 2026.